In a large university hospital, the rate of noncompliance with the Infectious Diseases Society of America guidelines for treatment of catheter-related bloodstream infection (CRBSI) was 44% during 52 consecutively observed episodes of CRBSI. To decrease noncompliance, the physicians who provided care to the next 46 patients with CRBSI received standardized treatment advice by electronic mail. This simple and not labor-intensive intervention decreased guideline noncompliance from 44% to 15% ( ). P ! .01
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Use of Semiautomatic Treatment
Advice to Improve Compliance with Infectious Diseases Society of America Guidelines for Treatment of Intravascular Catheter-Related Infection: A Before-After Study lococci can be treated with a short course of antibiotics. The scientific evidence on which these guidelines are based is fragmented and is not always derived from adequately powered controlled trials, but it is the best evidence available.
This study was aimed at evaluating whether, in our hospital, the antibiotic treatment given to patients with CRBSIs is in accordance with the IDSA guidelines. In the second stage of the study, the value of making semiautomatic and standardized treatment advice based on these guidelines available to physicians was evaluated.
Methods. The study used a prospectively planned beforeafter design. During the first stage, which was 8 months long, all intravascular catheter tips that were cultured at our 1700-bed tertiary care hospital were prospectively checked daily. When culture of a catheter tip from an adult patient yielded у1000 cfu [5] , blood cultures were checked. CRBSI was confirmed when у1 blood culture (у2 for coagulase-negative staphylococci) of a sample obtained р72 h before catheter removal grew the phenotypic strain seen on the catheter-tip culture. Strain identifications were made by antibiogram and species, using the Vitek system (bioMérieux). Patients for whom samples from body sites other than blood yielded the strain seen on the catheter-tip culture were excluded.
In this stage of the study, the antibiotic treatment administered by the attending physician was recorded, without notification of the physician that it was recorded, and no treatment advice was given. The institutional review board at our hospital gave permission to conduct the study, because the final goal was to improve CRBSI management in the long term.
During the second study stage, which was 7 months long, when CRBSI was detected, standardized treatment advice was sent to the attending physician by electronic mail. The electronic mailbox is part of the computerized medical record. In addition, a printout was put on the physician's desk on the ward. No person-to-person advice was given. Nine sets of standardized advice were created (available from B.J.A.R. on request by e-mail), on the basis of the IDSA guidelines, for treatment of the bacteria listed in table 1. Because of difficulty of giving standardized advice for treatment of CRBSI caused by nonalbicans Candida species, attending physicians were advised to ask for a patient-specific expert opinion from the infectious diseases physicians in such cases. Only in cases of gram-negative bacterial CRBSI was it required that we finish (finalize) the standardized treatment advice by selecting the preferred antibiotic treatment from several options before sending the advice to the attending physician. No advice was prepared for treat- ment of infections caused by vancomycin-resistant enterococci, because this type of infection currently is extremely rare in our hospital (no case occurred during the entire study).
To standardize the evaluation of the treatment that was given, clinically realistic and predefined rules based on the IDSA guidelines were used (table 1). Treatment also was considered to be inadequate when it was not started on the day that advice was given. When one of the investigators was contacted for further advice, and the antibiotic treatment regimen was changed after the physicians reached mutual agreement (e.g., because another infection needed treatment simultaneously), the treatment was considered to be adequate. When a complicated infection with Staphylococcus aureus, enterococci, yeasts, or gram-negative rods (e.g., endocarditis and spondylodiscitis) was diagnosed, a treatment regimen of !28 days' duration was considered to be inadequate. When the dose administered was lower than the preset lowest acceptable dose, treatment was still considered to be adequate if it was in accordance with the dose for decreased renal function recommended in the Sanford Guide to Antimicrobial Therapy 2002 -2003 .
To demonstrate a reduction in the rate of noncompliance with the guidelines of 66% (90% power;
), taking into a p 0.05 account the 44% noncompliance rate (treatment administered to 23 of 52 patients did not comply with IDSA guidelines; see Results) observed during the first stage of the study, we needed to make 42 observations after the intervention. A 2-sided x 2 test was used to compare proportions. GraphPad Prism, version 3.02 (GraphPad Software), was used for analysis, and nQuery Advisor, version 3.0 (Statistical Solutions), was used for samplesize calculations.
Results. During the first stage of the study, 1675 cathetertip cultures were performed, of which 247 yielded у1000 cfu.
The results of simultaneous blood cultures for 97 of these patients were also positive. For 71 patients, the phenotypic strain isolated from the blood sample was the same as that from the catheter tip; in these cases, the patients were considered to have a CRBSI. Nineteen of these 71 patients were treated in the intensive care unit (ICU).
The treatment administered to 24 of the 71 patients was not in accordance with the IDSA guidelines (table 2). In 14 of these 24 patients, CRBSI was caused by organisms other than coagulase-negative staphylococci. Twelve of the 24 patients received no antibiotic treatment (6 of these patients were infected with organisms other than coagulase-negative staphylococci). Other reasons for noncompliance are listed in table 2.
Treatment given to ICU patients was in accordance with the IDSA guidelines much more frequently than was that given to non-ICU patients ( ). For 14 of the 52 non-ICU patients, the P ! .01 attending physicians requested consultation with one of the infectious diseases physicians. For 1 of these 14 patients, the treatment subsequently administered was not in compliance with the IDSA guidelines (the patient had coagulase-negative staphylococcal CRBSI and received no antibiotic therapy).
Because our analysis revealed that treatment administered to ICU patients was in accordance with the IDSA guidelines for all but 1 patient, only non-ICU patients were included in the second stage of the study. CRBSI was diagnosed in 46 non-ICU patients during the second stage. Treatment regimens administered to 39 of 46 patients were in accordance with the IDSA guidelines. When the rate of noncompliance among non-ICU patients before the intervention was compared with that after the intervention (23 [44%] of 52 vs. 7 [15%] of 46 patients), the difference was statistically significant ( ). P p .004 When the number of patients whose attending physicians consulted with infections diseases physicians (whether by telephone or bedside) before the intervention was compared with the number after the intervention, no statistically significant increase was noted (14 [27%] of 52 vs. 15 [33%] of 46 patients;
). This indicates that the semiautomatic treatment advice P p .5 intervention did not increase the workload of the infectious diseases physicians.
Discussion. The number of published clinical guidelines is ever-increasing, but implementation can be difficult. In the present study, we observed that, before the implementation of semiautomatic treatment advice, compliance with IDSA guidelines for the treatment of CRBSI was poor (56%) among non-ICU patients. The noncompliance rate significantly decreased (to 15%) after the intervention.
What are possible reasons for noncompliance with IDSA guidelines among non-ICU patients? In patients with CRBSI, symptoms often disappear promptly after catheter removal. Therefore, results of cultures obtained when the patient was still symptomatic may not always be taken into account later. In contrast, in the ICU, microbiological results are screened daily. Furthermore, an ICU patient with a CRBSI is less likely to be ready for discharge after catheter removal than is a non-ICU patient. Therefore, it is more acceptable for the treating physician to administer antibiotics for у10 days to an ICU patient. In addition, a lack of awareness of the guidelines and a lack of knowledge about the risk of metastatic complications can lead to noncompliance.
The intervention we studied increased the workload of the infectious diseases physicians only minimally. In our 1700-bed tertiary care hospital, on average, only 1 positive catheter-tip culture per day was found. Therefore, blood culture results and other microbiological information were checked for only 1 patient per day. Medical files at our institution are fully computerized, and microbiological and technical/radiological information can be checked instantly. As a result, implementing the intervention required !10 min per day.
Several studies have investigated the use of clinical decision support systems for the prevention and treatment of disease [7] . Such interventions have mostly, but not uniformly, been found to be beneficial. Our intervention was not fully computerized but was straightforward and not labor-intensive, and no expensive new software was needed.
Our study has some limitations. Such an intervention is likely to be more difficult to implement in hospitals without electronic medical records. We could not include patients who had sepsis and positive results of a catheter-tip culture but for whom no blood cultures had been done or patients with CRBSI for whom the catheter was not removed. Therefore, the intervention studied can complement but not replace outreach visits by the infectious diseases physician. Because an in-house online formularium is available (with instructions for the appropriate dosage for bacteremia), and to keep the advice from becoming too exhaustive, we decided not to include instructions on dosage. Furthermore, it is the policy in our hospital to monitor serum drug levels in all patients who are receiving vancomycin. Therefore, this was used as a criterion for adequacy, although this is not specifically mentioned in the IDSA guidelines, and nomograms are probably a valuable alternative in patients with stable renal function.
Because in the majority of cases in which the treatment during the first stage of the study was not in agreement with the guidelines, treatment consisted of removal of the catheter without administration of antibiotics (or administration of antibiotics for too short a time), increased compliance after the intervention increased the use of antibiotics to treat CRBSI. Whether this increase can lessen the need for antibiotics later to treat complications of inadequately managed CRBSIs remains unproven.
In conclusion, an easy-to-implement system in which standardized advice for treatment of CRBSI was supplied to attending physicians was created. This system significantly improved compliance with IDSA guidelines.
